ProPhase Labs (PRPH) Scheduled to Post Quarterly Earnings on Wednesday

ProPhase Labs (NASDAQ:PRPH) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter.

ProPhase Labs (NASDAQ:PRPH) last issued its earnings results on Wednesday, August 14th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.25). ProPhase Labs had a negative net margin of 146.39% and a negative return on equity of 54.04%. The firm had revenue of $2.47 million during the quarter. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ProPhase Labs Stock Down 5.3 %

Shares of NASDAQ:PRPH opened at $0.74 on Tuesday. ProPhase Labs has a 52 week low of $0.66 and a 52 week high of $7.48. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 1.58. The company has a market capitalization of $14.10 million, a PE ratio of -0.61 and a beta of -0.10. The company has a 50 day moving average price of $2.31 and a two-hundred day moving average price of $3.35.

About ProPhase Labs

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.